OMBP Projected Dividend Yield
Omni Bio Pharmaceutical Inc ( OTCBB : OMBP )Omni Bio Pharmaceutical is a development stage biopharmaceutical company. Co. is engaged in exploring methods of use of AAT. AAT is a naturally occurring protein that is essential for normal liver and lung function and has historically been purified from human blood (p-AAT) to treat patients suffering from emphysema due to AAT-deficiency. Co. holds licenses for method of use issued patent claims for the use of p-AAT in the treatment of diabetes, certain bacterial and viral diseases and cellular transplantation and graft rejection. Co. also holds licenses for method of use patent application claims for the use of p-AAT in the treatment of radiation protection and myocardial remodeling. 20 YEAR PERFORMANCE RESULTS |
OMBP Dividend History Detail OMBP Dividend News OMBP Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |